Tag Archives: Timothy Ramey
Brown-Forman B (BF.B) Gets a Buy Rating from Pivotal Research
In a report released yesterday, Timothy Ramey from Pivotal Research reiterated a Buy rating on Brown-Forman B (BF.B – Research Report), with a price target of $65. The company’s shares closed last Monday at $58.68, close to its 52-week high
Nu Skin (NUS) Receives a Buy from Pivotal Research
In a report released today, Timothy Ramey from Pivotal Research reiterated a Buy rating on Nu Skin (NUS – Research Report), with a price target of $70. The company’s shares closed yesterday at $38.54, close to its 52-week low of
Tyson Foods (TSN) Receives a Sell from Pivotal Research
In a report released today, Timothy Ramey from Pivotal Research maintained a Sell rating on Tyson Foods (TSN – Research Report), with a price target of $50. The company’s shares opened today at $83.14, close to its 52-week high of
Analysts Are Bullish on These Consumer Goods Stocks: USANA Health (USNA), Crocs (CROX)
There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on USANA Health (USNA – Research Report) and Crocs (CROX – Research Report) with bullish sentiments. USANA Health (USNA) In a report
Pivotal Research Thinks USANA Health’s Stock is Going to Recover
In a report released today, Timothy Ramey from Pivotal Research reiterated a Buy rating on USANA Health (USNA – Research Report), with a price target of $75. The company’s shares opened today at $63.39, close to its 52-week low of
Pivotal Research Believes Brown-Forman B (NYSE: BF.B) Won’t Stop Here
Pivotal Research analyst Timothy Ramey maintained a Buy rating on Brown-Forman B (BF.B – Research Report) yesterday and set a price target of $65. The company’s shares closed yesterday at $54.10, close to its 52-week high of $55.08. According to
